We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+21.28%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$2.3B
AUM Growth
+$384M
Cap. Flow
+$216M
Cap. Flow %
9.39%
Top 10 Hldgs %
49.4%
Holding
255
New
116
Increased
33
Reduced
43
Closed
21

Top Sells

Rank Stock Value
1
WDC icon
Western Digital
WDC
+$29.7M
2
QURE icon
uniQure
QURE
+$26.4M
3
LLY icon
Eli Lilly
LLY
+$21.8M
4
BBIO icon
BridgeBio Pharma
BBIO
+$19.6M
5
SNDK
Sandisk
SNDK
+$16.4M

Sector Composition

Rank Sector Weight
1 Healthcare 21.71%
2 Financials 6.94%
3 Consumer Discretionary 6.7%
4 Industrials 3.7%
5 Technology 3.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QURE icon
26
CALL
uniQure
QURE
$3.01B
$17.9M 0.78%
+750,100
New +$28.9M
BDX icon
27
Becton Dickinson
BDX
$46.5B
$17.5M 0.76%
+90,000
New +$17.1M
SRPT icon
28
Sarepta Therapeutics
SRPT
$1.62B
$17.4M 0.76%
810,000
-180,000
-18% -$3.79M
B
29
Barrick Mining
B
$62.2B
$17.4M 0.76%
400,000
-350,000
-47% -$13.1M
MSTR icon
30
PUT
Strategy Inc
MSTR
$34.9B
$17M 0.74%
111,700
-26,900
-19% -$6.19M
GOSS icon
31
Gossamer Bio
GOSS
$82.6M
$16.1M 0.7%
5,190,800
+131,600
+3% +$376K
HRMY icon
32
Harmony Biosciences
HRMY
$2.02B
$15.5M 0.68%
415,000
+133,000
+47% +$4.37M
KNOP icon
33
KNOT Offshore Partners
KNOP
$368M
$15.1M 0.66%
1,460,000
-402
-0% -$3.9K
UNH icon
34
UnitedHealth
UNH
$378B
$14.9M 0.65%
45,000
-3,000
-6% -$1.02M
IAG icon
35
IAMGOLD
IAG
$8.38B
$14.8M 0.65%
900,000
ELV icon
36
Elevance Health
ELV
$82.3B
$14.7M 0.64%
42,000
+24,000
+133% +$8.11M
ARIS
37
Aris Mining
ARIS
$2.91B
$14.6M 0.64%
900,000
GUTS icon
38
Fractyl Health
GUTS
$110M
$13.3M 0.58%
6,047,620
+1,397,620
+30% +$2.25M
CCOI icon
39
Cogent Communications
CCOI
$669M
$12.9M 0.56%
600,000
-50,000
-8% -$1.48M
COIN icon
40
PUT
Coinbase
COIN
$40.1B
$11.9M 0.52%
52,500
-8,500
-14% -$2.53M
SUNC
41
SunocoCorp LLC
SUNC
$3.91B
$11.6M 0.5%
+235,000
New +$11.8M
FOLD
42
DELISTED
Amicus Therapeutics
FOLD
$11.4M 0.5%
800,000
-35,000
-4% -$344K
GOOGL icon
43
Alphabet (Google) Class A
GOOGL
$4.58T
$11.3M 0.49%
36,000
MEDP icon
44
PUT
Medpace
MEDP
$16.1B
$11.2M 0.49%
20,000
LXEO icon
45
Lexeo Therapeutics
LXEO
$323M
$11.1M 0.48%
1,120,000
+197,338
+21% +$1.8M
HIMS icon
46
PUT
Hims & Hers Health
HIMS
$7.12B
$11M 0.48%
340,000
+30,000
+10% +$1.28M
LEN.B icon
47
Lennar Class B
LEN.B
$20B
$10.9M 0.48%
115,000
TGTX icon
48
TG Therapeutics
TGTX
$7.08B
$10.7M 0.47%
360,000
+35,000
+11% +$1.14M
INSE icon
49
Inspired Entertainment
INSE
$182M
$9.93M 0.43%
1,061,044
-63,956
-6% -$539K
VTYX
50
DELISTED
Ventyx Biosciences
VTYX
$9.39M 0.41%
1,040,000
+40,000
+4% +$299K

Similar funds

683 Capital Management's Q4 2025 Portfolio in Review

As of Q4 2025, 683 Capital Management held 255 positions worth $2.3B, up 20% from $1.91B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

683 Capital Management deployed $216M of net new capital in Q4 2025, opening 116 new positions and adding to 33 existing holdings. Its largest new stake was Kaspi.kz JSC: 265,000 shares worth $20.7M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Western Digital, an estimated $29.7M trimmed.

  • 683 Capital Management's largest Q4 2025 buy was Kaspi.kz JSC: 265,000 shares worth $20.7M.
  • 683 Capital Management added most to Mereo BioPharma in Q4 2025, an estimated $19.3M increase.
  • 683 Capital Management's biggest Q4 2025 reduction was Western Digital, cutting an estimated $29.7M.
  • 683 Capital Management fully exited Eli Lilly in Q4 2025, selling an estimated $21.8M.
  • 683 Capital Management's ten largest holdings make up 49% of its $2.3B portfolio in Q4 2025.
  • 683 Capital Management opened 116 new positions and closed 21 in Q4 2025.
  • 683 Capital Management's portfolio value rose 20% quarter-over-quarter to $2.3B.

Based on 683 Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.